These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8313875)
1. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. Francis SE; Gluzman IY; Oksman A; Knickerbocker A; Mueller R; Bryant ML; Sherman DR; Russell DG; Goldberg DE EMBO J; 1994 Jan; 13(2):306-17. PubMed ID: 8313875 [TBL] [Abstract][Full Text] [Related]
2. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. Gluzman IY; Francis SE; Oksman A; Smith CE; Duffin KL; Goldberg DE J Clin Invest; 1994 Apr; 93(4):1602-8. PubMed ID: 8163662 [TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole. Luker KE; Francis SE; Gluzman IY; Goldberg DE Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673 [TBL] [Abstract][Full Text] [Related]
4. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. Goldberg DE; Slater AF; Beavis R; Chait B; Cerami A; Henderson GB J Exp Med; 1991 Apr; 173(4):961-9. PubMed ID: 2007860 [TBL] [Abstract][Full Text] [Related]
5. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Banerjee R; Liu J; Beatty W; Pelosof L; Klemba M; Goldberg DE Proc Natl Acad Sci U S A; 2002 Jan; 99(2):990-5. PubMed ID: 11782538 [TBL] [Abstract][Full Text] [Related]
6. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum. Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719 [TBL] [Abstract][Full Text] [Related]
7. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Dame JB; Reddy GR; Yowell CA; Dunn BM; Kay J; Berry C Mol Biochem Parasitol; 1994 Apr; 64(2):177-90. PubMed ID: 7935597 [TBL] [Abstract][Full Text] [Related]
8. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Francis SE; Sullivan DJ; Goldberg DE Annu Rev Microbiol; 1997; 51():97-123. PubMed ID: 9343345 [TBL] [Abstract][Full Text] [Related]
9. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D. Dali B; Keita M; Megnassan E; Frecer V; Miertus S Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033 [TBL] [Abstract][Full Text] [Related]
10. Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets. Moon RP; Bur D; Loetscher H; D'Arcy A; Tyas L; Oefner C; Grueninger-Leitch F; Mona D; Rupp K; Dorn A; Matile H; Certa U; Berry C; Kay J; Ridley RG Adv Exp Med Biol; 1998; 436():397-406. PubMed ID: 9561248 [No Abstract] [Full Text] [Related]
11. Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. Bonilla JA; Bonilla TD; Yowell CA; Fujioka H; Dame JB Mol Microbiol; 2007 Jul; 65(1):64-75. PubMed ID: 17581121 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. Francis SE; Banerjee R; Goldberg DE J Biol Chem; 1997 Jun; 272(23):14961-8. PubMed ID: 9169469 [TBL] [Abstract][Full Text] [Related]
13. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746 [TBL] [Abstract][Full Text] [Related]
14. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. Le Bonniec S; Deregnaucourt C; Redeker V; Banerjee R; Grellier P; Goldberg DE; Schrével J J Biol Chem; 1999 May; 274(20):14218-23. PubMed ID: 10318841 [TBL] [Abstract][Full Text] [Related]
15. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes. Naughton JA; Nasizadeh S; Bell A Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341 [TBL] [Abstract][Full Text] [Related]
16. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012). Pérez B; Teixeira C; Gomes JR; Gomes P Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416 [TBL] [Abstract][Full Text] [Related]
17. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. Moura PA; Dame JB; Fidock DA Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273 [TBL] [Abstract][Full Text] [Related]